Key result
Propofol-remifentanil combination successfully managed anesthesia in a 28-year-old male patient with neuroleptic malignant syndrome undergoing eight electroconvulsive therapy sessions.
Case Report (n=1)
Propofol-remifentanil combination can be successfully used for anesthesia management during electroconvulsive therapy in patients with neuroleptic malignant syndrome.
Supports feasibility of propofol-remifentanil for ECT anesthesia in NMS; leaves open need for controlled trials before wider use.
Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific challenges. This case report describes successful management of anesthesia in 28-year-old male patient undergoing eight electroconvulsive therapy sessions for treatment of neuroleptic malignant syndrome.
No takes yet. Share an insight, caveat, or question.
Arasteh et al. (2012) conducted a case report in Neuroleptic malignant syndrome (n=1). Propofol-Remifentanil Combination was evaluated on Management of anesthesia. Propofol-remifentanil combination successfully managed anesthesia in a 28-year-old male patient with neuroleptic malignant syndrome undergoing eight electroconvulsive therapy sessions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: